We compared the potency of the interaction of three antipsychotic drugs, i.e., chlorpromazine (CPZ), haloperidol (HAL) and sulpiride (SUL), with the plasma membrane in the rat brain. CPZ loading (≥ 100 μM) dose-dependently increased both membrane permeability (assessed as [
Introduction
Antipsychotic drugs have been widely used to treat schizophrenia as well as other psychiatric disorders, but the use of these drugs is limited by their tendency to produce extrapyramidal movement disorders such as tardive dyskinesia (TD) (Gerlach and Casey, 1988) and parkinsonism (Marsden and Jenner, 1980) . Although receptors dominate most research on antipsychotic drugs, such small molecular weight, lipid-soluble compounds would easily distribute into the plasma membrane and affect the membrane environment (Meltzer et al., 1996; Tharmapathy et al., 2000) . However, little is known about the effects of these drugs on plasma membrane integrity in the central nervous system.
While most previous studies compared the cytotoxic effect of antipsychotic drugs on non-neuronal cell types (Boelsterli et al., 1987; Dwyer et al., 2003) , little is known about the difference among these drugs in the potency to induce neurotoxicity, especially in the potency to interact with the plasma membrane in the central nervous system. Radio-labeled 2-deoxy-D-glucose (2DG) have been used as a probe for cell membrane permeability alterations detected by monitoring the leakage of the phosphorylated 2DG from the cells (Andreoli et al., 1985; Walum and Peterson, 1982) .
Membrane fluidity is measured as the rotational mobility of a fluorescent probe 1,6-diphenyl-1,3,5-hexatriene (DPH) which partitions into the membrane bilayer (Shinitzky and Barenholz, 1978) . A decrease in the fluorescence polarization of DPH indicates an increase in the membrane fluidity (Ohyashiki et al., 1992) .
In the present study, the potency of the interaction of three antipsychotic drugs, i.e., chlorpromazine (CPZ; a phenothiazine antipsychotic drug), haloperidol (HAL; a butyrophenone antipsychotic drug), and sulpiride (SUL; a benzamide antipsychotic drug), with the plasma membrane in the rat brain was examined and compared. To investigate the effects of these antipsychotic drugs on plasma membrane permeability,
18 F]FDG) uptake in fresh rat brain slices was serially and two-dimensionally measured using a dynamic positron autoradiography technique (Murata et al., 1999; Omata et al., 2000) . Also, to investigate the effects of these agents on plasma membrane fluidity, plasma membrane anisotropy in the rat brain was measured spectrofluorometrically using DPH as a fluorescent probe.
Methods

Dynamic positron autoradiography technique
All animal procedures were approved by the Animal Care and Use Committee of University of Fukui in accordance with Guidelines for Animal Experiments, University of Fukui. Male Wistar rats (250-300 g) were decapitated, and their brains were removed. Sagittal brain slices (300 µm in thickness) were prepared with a microslicer (DTK-2000, Dosaka EM, Kyoto, Japan), and incubated as previously described (Murata et al., 1999; Omata et al., 2000) . USA) with a solvent system of acetonitrile/water (95:5). The metabolites in the incubation medium were sampled after the administration of antipsychotic drugs and separated by TLC. The TLC plates were exposed to a radioluminography plate.
Fluorescence anisotropy measurement
The synaptosome fraction was prepared as previously reported (Gray and Whittaker, 1962) . Briefly, the rat brain tissue was homogenized in 10 vol of 0.32 M sucrose using an Ultrasonic Disrupter (UR-20P, Tomy Seiko Co. Ltd., Tokyo, Japan).
Each homogenate was centrifuged at 1000 g and 4°C for 10 min. The supernatant was removed and centrifuged at 12000 g and 4°C for 20 min. The resultant pellet was suspended in 20 vol of 50 mM Tris-HCl buffer, pH 7.4, and washed twice by centrifugation at 12000 g and 4°C for 20 min. The final pellet, resuspended in the same buffer, was used for the measurement of membrane anisotropy.
Membrane anisotropy was measured by the method of Shinitzky and Inbar (1976) and Ohyashiki et al. (1992) . Briefly, membranes were diluted in 50 mM Tris-HCl buffer, pH 7.4, and mixed with the fluorescent probe DPH (0.8 mg protein/ml, 3.3 µM DPH). The DPH stock solution (1 mM) was prepared in tetrahydrofuran. The mixture was incubated at 25°C for 10 min, the reaction was stopped by the addition of a large volume of buffer, and the mixture was centrifuged at 15000 g and 4°C for 20 min. The obtained pellet was washed twice with the buffer and resuspended in the same buffer.
Various concentrations of antipsychotic drugs were added to DPH-labeled membrane solutions (0.07 mg protein/ml) and incubated at 36°C for 10 min. The final concentration of the vehicle (DMSO) in the reaction mixture was 0.5%. DMSO alone at this concentration had no effect on membrane fluidity. Fluorescence measurements were carried out at 36°C with a Beacon 2000 fluorescence polarization system (Invitrogen Corporation, San Diego, CA, USA). The excitation and emission wavelengths were 330 and 420 nm, respectively. The steady-state fluorescence polarization (P) was expressed using the formula (Shinitzky and Barenholz, 1978):
where I ║ and I ┴ are the emission intensities parallel and perpendicular, respectively, to the plane of the excitation light. "Anisotropy" is a term often used in the fluorescence polarization field, and is also inversely related to fluidity. The fluorescence anisotropy (A) was calculated from the fluorescence polarization value using the formula (Shinitzky and Barenholz, 1978) :
Protein amounts were measured with a Bio-Rad protein assay kit (Hercules, CA, USA) using bovine serum albumin as the standard. 
Statistical analysis
The presented values are shown as the means ± SD. The Mann-Whitney U-test was used to evaluate the significance of differences, and a p value of less than 0.05 was considered significant. The slope of the graph for 30 μM CPZ was definitely increased during the entire time course. However, when slices were loaded with buffer containing ≥ 100 μM CPZ, the slope of the graph initially increased, then gradually decreased and finally became negative (this finding may reflect the outflow of [ 18 F]FDG metabolites from brain slices). The time it took to reach a negative value was shortened as the drug concentration was increased (results for 30, 100, and 300 μM are shown in Figure 2(a) ).
Results
Similar results were obtained in each of the regions examined (data not shown). The slope of the graph for ≤ 100 μM HAL was similar to that for the control, but that for 300 μM HAL was definitely increased during the entire time course. However, when slices were loaded with buffer containing 1 mM HAL, the slope of the graph initially increased, then gradually decreased and finally became negative (results for 100, 300
μM and 1 mM are shown in Figure 2 Relatively low concentrations of CPZ (30 μM) induced no significant changes in anisotropy, while relatively high concentrations of CPZ (≥ 100 μM) induced a dose-dependent decrease in fluorescence anisotropy (i.e., an increase in membrane fluidity) (Figure 3(a) ). Upon treatment with HAL, a significant decrease in anisotropy was observed only at the concentration of 1 mM (results for 300 μM and 1mM are shown in Figure 3(b) ). However, the addition of SUL did not induce any significant change in anisotropy at any of the concentrations tested (results for 300 μM and 1 mM T. Murata et al. 10 are shown in Figure 3(b) ).
Discussion
Our findings indicated the following ranking of the potency to induce plasma membrane permeabilization and fluidization: CPZ > HAL > SUL. This order of ranking was in good accord with the ranking of the relative cytotoxicity induced by these agents in various types of cells (Boelsterli et al., 1987; Dwyer et al., 2003) .
Both CPZ and HAL are amphiphilic drugs (Pappu and Hauser, 1981) . Amphiphilic molecules are reported to penetrate into membrane, make disordered regions in lipid packing and enhance the permeability of membrane (Katsu et al., 1987 (Katsu et al., , 1989 (Katsu et al., , 1990 (Katsu et al., , 1993 . Therefore, in the present study, the amphiphilic properties of the drugs may have enhanced permeability and fluidity of the plasma membrane of brain cells. The lipophilicity of the drugs is indicated as one of the non-receptor-mediated mechanisms (Goosey and Doggett, 1983) . These raise the possibility that the differences among the drugs in the potency to interact with the plasma membrane revealed in our study would partly underlie the differences among the drugs in the potency to induce cytotoxic effects reported in previous studies (Boelsterli et al., 1987; Dwyer et al., 2003) .
Our data showed that glycolytic activity was enhanced by relatively low concentrations of CPZ (≥ 30 µM) and high concentrations of HAL (300 µM and 1 mM).
This would arise due to the amphiphilic property of CPZ and HAL, since an increase in glycolytic activity as a consequence of increased ATP consumption and ATP depletion due to the amphiphilic action on the plasma membrane has been reported (Rissanen et al., 2003) . Another possible explanation for the enhancement of glycolytic activity is that a compensation for the inhibition of oxidative phosphorylation by CPZ and HAL at the mitochondrial respiratory chain level, since these drugs are known to inhibit mitochondrial complex I activity (Burkhardt et al., 1993) .
One of the limitations of our findings is that the concentrations of antipsychotic drugs used in our study were higher than the therapeutic concentrations in human plasma, which range from 0.2 to 2.0 µM (Curry et al., 1970; Ulrich et al., 1998) .
Besides, in vivo, greater than 90% of the drug is bound to the red blood cells and plasma protein and 10% is the free drug (Brinkschulte et al., 1982) , which is the pharmacologically active portion. However, due to their large distribution volumes, these drugs can accumulate at 20-to 30-fold higher concentrations in brain tissue than in serum (Baldessarini et al., 1993; Kornhuber et al., 1999) . The high lipophilicity of these drugs also enables them to concentrate in the membrane as high as 1000-fold greater than the concentration in aqueous solution (Seeman, 1977) . Therefore, these drugs may reach neurotoxic levels in the brain.
The membrane fluidization induced by antipsychotic drugs could result in the fusion between the synaptic vesicle membrane and the presynaptic membrane, which may enhance spontaneous secretion of dopamine and thus underlie TD (Seeman et al., 1974) . Membrane permeabilization could cause neuronal degeneration and death, which has been proposed as a toxic mechanism of Parkinson's disease (Volles et al., 2001 ).
These considerations lead us to speculate that membrane permeabilization and fluidization by antipsychotic drugs may play at least a partial role in the pathogenesis of drug-induced extrapyramidal side effects such as parkinsonism and TD.
At present, little has been reported about the comparative potencies of different antipsychotic drugs for inducing extrapyramidal adverse effects. SUL is considered to be a drug with a documented lower risk of these unwanted effects in human (Gerlach and Casey, 1984; Spila-Alegiani et al., 1995) and in an animal model (Gunne et al., 1986) . Although the mechanisms responsible for the differential incidence of extrapyramidal adverse effects among antipsychotic drugs are uncertain, these observations prompt us to speculate that SUL may have a lower probability of inducing extrapyramidal side effects such as parkinsonism and TD than HAL and CPZ, partly due to its lower potency for interacting with the plasma membrane, as revealed in our study.
Further studies will be needed to clarify the relationship between the membrane actions of antipsychotic drugs and the pathogenesis of antipsychotic drug-induced extrapyramidal side effects.
In conclusion, we compared for the first time the potency of the interaction of three antipsychotic drugs, CPZ, HAL and SUL, with the plasma membrane in the rat brain. CPZ permeabilized and fluidized plasma membrane at relatively low concentrations (≥ 100 μM). HAL required a higher concentration (1 mM) to induce these effects. SUL did not act on the membrane even at a high concentration (1 mM).
These findings implied the following order of the potency to interact with the plasma membrane: CPZ > HAL > SUL, which may be partly responsible for the difference among the drugs in the probability of inducing extrapyramidal side effects such as parkinsonism and TD. 
